靶点针对疾病信息25(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
标题
内容
INDICATI
Approved Lung cancer [ICD-11: 2C25]
INDICATI
Approved Malignant intestine neoplasm [ICD-11: 2C0Z]
INDICATI
Approved Mastocytosis [ICD-11: 2A21]
INDICATI
Approved Mature B-cell lymphoma [ICD-11: 2A85]
INDICATI
Approved Peritoneal cancer [ICD-11: 2C51]
INDICATI
Phase 4 Multiple myeloma [ICD-11: 2A83]
INDICATI
Phase 3 Acute diabete complication [ICD-11: 5A2Y]
INDICATI
Phase 3 Breast cancer [ICD-11: 2C60-2C6Y]
INDICATI
Phase 3 Endometrial cancer [ICD-11: 2C76]
INDICATI
Phase 2 Macular degeneration [ICD-11: 9B75]
INDICATI
Phase 2 Non-small cell lung cancer [ICD-11: 2C25]
INDICATI
Phase 2 Retinopathy [ICD-11: 9B71]
INDICATI
Phase 2 Stomach cancer [ICD-11: 2B72]
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3